| Literature DB >> 35968012 |
Xinjian Wang1, Zhen Yang1, Yujun Zhang1, Feng Cheng1, Xiaoyong Xing2, Fengqin Wen2, Yonghao Hu2, Changjiang Chen3, Bin Wei3, Pengxia Bai4, Xuehong Wang1, Yu Liu1, Hongjuan Zhang1, Baocheng Hao1, Shengyi Wang1.
Abstract
Melophagus ovinus disease is a common ectoparasitosis, which can lead to a decrease in animal production performance, product quality, and even death. Aconitum flavum Hand.-Mazz. has many pharmacological activities including insecticidal, heat-clearing, analgesic, and dehumidifying. However, there are few researches focused on the effects and related mechanism of Aconitum flavum Hand.-Mazz. in killing Melophagus ovinus. In this study, 11 alkaloids of Aconitum flavum Hand.-Mazz. were detected, and its total alkaloid activity was determined. The results showed when the total alkaloid concentration was 64 mg/ml and the treatment time was 16 h, the killing rate of Melophagus ovinus reached 100%. Through the observation of the differences in the surface of Melophagus ovinus in each experimental group, it was found that the morphology of the posterior end of the female Melophagus ovinus in the alkaloid treatment group was significantly different from that of the blank and positive control groups, and most of the epidermal tissue was obsessive and missing. Moreover, the enzyme activity determination results of 64 mg/ml group were significantly different when compared with the normal control group, while there was no significant difference in other groups. Then, the Melophagus ovinus gene library was established by the unreferenced genome transcriptome sequencing, the proteomic comparison was performed using tandem mass tag labeled protein detection technology, and finally, the samples were quantitatively analyzed by liquid chromatography-mass spectrometry tandem and bioinformatics methods. Based on the above experimental results, it was speculated that Aconitum flavum Hand.-Mazz. total alkaloids may cause the imbalance of protein disulfide isomerase expressions by affecting the regulation of Hsp40 cellular protein homeostasis and the oxidation of protein disulfide isomerase and related proteins. This would affect the selective recognition of signal sequence, the targeted transport of Sec 61, and the correct folding of the three-dimensional structure of amino acid chain, weakening the clearance of amino acid chains that cannot be correctly folded and eventually resulting in the killing of Melophagus ovinus. This study preliminarily revealed the mechanism of Aconitum flavum Hand.-Mazz. total alkaloids against Melophagus ovinus and provided a theoretical basis for the screening of Melophagus ovinus action targets and the development of new veterinary drugs.Entities:
Keywords: TMT labeled quantitative proteomics; killing activity; mechanism; melophagus ovinus; total alkaloids
Year: 2022 PMID: 35968012 PMCID: PMC9365070 DOI: 10.3389/fvets.2022.951058
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1(A) HPLC diagram of aconitine standard. (B) HPLC diagram of AFHM total alkaloids. (C) Q-TOF total ion chromatograms of AFHM total alkaloids; (D) Ion m/z diagram of the main component 3-deoxyaconitrile of AFHM total alkaloids.
Results of Q-TOF tandem mass spectrometry analysis of AFHM total alkaloids.
|
|
|
|
|
|
|---|---|---|---|---|
| 4.393 | C23H37NO6 | 6-O-Demethylneoline | 424.2657 |
|
| 4.743 | C22H31NO3 | Songorine | 358.2347 |
|
| 5.427 | C22H33NO3 | 12-epi-Napelline | 360.2499 |
|
| 6.461 | C24H39NO6 | Neoline | 438.2807 |
|
| 4.743 | C24H39NO7 | 10-Hydroxyneoline | 454.2757 |
|
| 1.559 | C25H41NO9 | Jesaconine | 499.2972 |
|
| 11.329 | C32H45NO10 | Benzoylaconitin | 604.3046 |
|
| 18.598 | C34H47NO10 | 3-Deoxyaconitine | 630.2853 |
|
| 14.847 | C33H45NO11 | Mesaconitine | 632.3371 |
|
| 18.598 | C36H49NO12 | Acetylaconitine | 680.3486 |
|
| 24.634 | C34H47NO11 | Aconitine | 647.4473 |
|
Figure 2Drug-time action curve of killing Melophagus ovinus with AFHM total alkaloids.
Figure 3Scanning electron microscopic observation on the body surface of Melophagus ovinus after drug action.
Figure 4The difference of enzyme activity in Melophagus ovinus after treated with AFHM total alkaloids for 16 h. (A) Enzyme activity of AchE; (B) Enzyme activity of CarE; (C) Enzyme activity of CAT; (D) Enzyme activity of GSH-Px; (E) Enzyme activity of MAO; (F) Enzyme activity of POD; (G) Enzyme activity of Ca2+ Mg2+-ATPase; (H) Body weight of melophagus ovinus. The results were expressed as the mean ± standard deviation of three independent experiments. The results were expressed as the mean ± standard deviation of three independent experiments. *P < 0.05 and **P < 0.01 when compared with the blank control group, #P < 0.05 and P < 0.01 compared with positive control group was considered statistically significant differences. The significant differences (P < 0.05) between groups were indicated by different letters.
Data filtering statistics.
|
|
|
|
| |
|---|---|---|---|---|
| A | 36,564,272 | 5,484,640,800 | 93.03 | 93.03 |
| B | 38,719,130 | 5,807,869,500 | 93.31 | 93.31 |
| C | 36,551,532 | 5,482,729,800 | 90.58 | 90.58 |
Sample: sample name; Clean reads No: number of high-quality sequences reads; Clean data (bp): base number of high-quality sequences; Clean reads %: the percentage of high-quality sequence reads in sequencing reads; Clean data %: the percentage of high-quality sequence bases in sequencing bases.
Overall statistics of sequence splicing results.
|
|
|
|
|---|---|---|
| Total Length (bp) | 159,105,995 | 43,731,675 |
| Sequence Number | 80,757 | 35,098 |
| Max. Length (bp) | 24,388 | 24,388 |
| Mean Length (bp) | 1970.18 | 1245.99 |
| N50 (bp) | 3,427 | 2,237 |
| N50 Sequence No. | 13,956 | 5,141 |
| N90 (bp) | 822 | 466 |
| N90 Sequence No. | 49,040 | 23,339 |
| GC% | 32.18 | 32.39 |
Total length (bp): total length of sequence; Sequence number: total number of sequences; Max. length (bp): maximum length of sequence; Mean length: average length of the sequence; N50 (bp): arrange all sequences from long to short, and add the sequence length in this order. When the added length reaches 50% of the total length of the sequence, the length of the last sequence; N90 (bp): arrange all sequences from long to short, and add the sequence length in this order. When the added length reaches 90% of the total length of the sequence, the length of the last sequence; N50 sequence No.: total number of sequences with length >N50; N90 sequence No.: total number of sequences with length >N90; GC%: GC content of the sequence.
Overview of protein identification.
|
|
|
|---|---|
| Unique peptides | 20,669 |
| Total spectrums | 491,699 |
| Quantifiable proteins | 2,681 |
| Peptides | 21,362 |
| Matched spectrums | 43,378 |
| Identified proteins | 2,906 |
1. Total spectra: number of total spectra, number of secondary spectra generated by mass spectrometry detection; 2. Matched spectra: number of effective spectra, the number of spectra matched with the theoretical secondary spectra; 3. Peptides: the number of identified peptides, and the number of peptide sequences resolved by the matching results; 4. Unique peptides: the number of identified unique peptides and the number of unique peptide sequences parsed from the matching results; 5. Identified proteins: the number of identified proteins, the number of proteins resolved through specific peptide segments. 6. Quantitative proteins: quantitative protein number, which is the number of proteins quantified through specific peptide segments.
Figure 5The results of protein identification and data quality control. (A) Statistics of protein identified; (B) Peptide length distribution; (C) Protein coverage distribution; (D) Molecular weight distribution; (E) Peptide number distribution of proteins.
Screening results of differential proteins.
|
|
|
|
|---|---|---|
| LZ/Control | 151 | 81 |
Figure 6The statistical results of the sample repeatability test and differentially expressed proteins. (A) Principal component analysis of quantitative protein; (B) Boxplot of relative standard deviation of protein quantitative values between replicates in each group; (C) Pearson correlation coefficient between two samples; (D) Statistics of differential protein; (E) Volcano map of differential proteins; (F) Heatmap of differential proteins.
Figure 7Annotation analysis of the differential proteins. (A) GO secondary annotation classification diagram of differential proteins; (B) Subcellular structure annotation classification map of differential proteins; (C) COG/KOG functional classification map of differential proteins; (D) Enrichment analysis of biological process; (E) Enrichment analysis of cellular component; (F) Enrichment analysis of molecular function; (G) Enrichment analysis of KEGG pathway; (H) Enrichment analysis of protein domain.
Figure 8Differentially expressed proteins enrichment trend during endoplasmic reticulum protein processing.
Figure 9Cluster analysis of differentially expressed proteins. (A) Classification diagram of differentially expressed proteins; (B) Functional enrichment heatmap of biological process in differential expression protein; (C) Functional enrichment heatmap of cellular component in differential expression protein; (D) Functional enrichment heatmap of KEGG pathway in differential expression protein; (F) Functional enrichment heatmap of protein domain in differential expression protein.
Figure 10The protein-protein interaction network. The circle in the figure represents the differential protein. Different colors represent the differential expression of the protein (green is the down-regulated protein and red is the up-regulated protein). The darker the color, the greater the difference multiple.